Intervention of PKC-θ as an immunosuppressive regimen

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Sun, Zuoming ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Allograft rejection; Autoimmunity; PKC ; T cell activation; T cell differentiation

Indexed keywords

EID: 84874194668     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00225     Document Type: Article

References (100)

1. Aguilo,J.I.,Garaude,J.,Pardo,J.,Vil-lalba, M.,andAnel,A. (2009).Protein kinase C-thetaisrequiredforNK cellactivationandinvivocontrolof tumor progression. J. Immunol. 182, 1972-1981.
2. Altman,A.,Isakov,N.,andBaier,G. (2000). ProteinkinaseCtheta:anew essential superstarontheT-cellstage. Immunol.Today 21, 567-573.
3. Anderson,K.,Fitzgerald,M.,Dupont, M., Wang,T.,Paz,N.,Dorsch, M., Healy,A.,Xu,Y.,Ocain,T., Schopf,L.,Jaffee,B.,andPicarella,D. (2006). MicedeficientinPKCtheta demonstrateimpairedinvivoTcell activationandprotectionfromT cell-mediatedinflammatorydiseases. Autoimmunity 39, 469-478.
4. Baier,G.,Baier-Bitterlich,G.,Meller, N., Coggeshall,K.M.,Giampa,L., Telford,D.,Isakov,N.,andAltman,A. (1994). Expressionandbiochemical characterizationofhumanprotein kinase C-theta. Eur.J.Biochem. 225, 195-203.
5. Baier-Bitterlich,G.,Uberall,F.,Bauer, B.,Fresser,F.,Wachter,H.,Grunicke, H., Utermann,G.,Altman,A.,and Baier,G. (1996).ProteinkinaseC-theta isoenzymeselectivestimulation of thetranscriptionfactorcomplex AP-1inTlymphocytes. Mol.Cell. Biol. 16, 1842-1850.
6. Barouch-Bentov,R.,Lemmens,E.E., Hu,J.,Janssen,E.M.,Droin,N. M., Song,J.,Schoenberger,S.P.,and Altman,A. (2005).Proteinkinase C-theta isanearlysurvivalfactor requiredfordifferentiationofeffec-torCD8+ T cells. J. Immunol. 175, 5126-5134.
7. Bauer,B.,Krumbock,N.,Ghaffari-Tabrizi,N.,Kampfer,S.,Villunger,A., Wilda,M.,Hameister,H.,Utermann, G., Leitges,M.,Uberall,F.,andBaier, G. (2000).TcellexpressedPKCtheta demonstratescell-typeselectivefunc-tion. Eur.J.Immunol. 30, 3645-3654.
8. Benoit, S.C.,Kemp,C.J.,Elias, C. F.,Abplanalp,W.,Herman,J. P.,Migrenne,S.,Lefevre,A.L., Cruciani-Guglielmacci,C.,Magnan, C., Yu,F.,Niswender,K.,Irani, B.G.,Holland,W.L.,andClegg, D.J. (2009).Palmiticacidmediates hypothalamic insulin resistanceby alteringPKC-thetasubcellularlocal-ization inrodents. J. Clin.Invest. 119, 2577-2589.
9. Berg,L.J.,Finkelstein,L.D.,Lucas,J.A., and Schwartzberg,P.L. (2005).Tec family kinasesin Tlymphocytedevel-opment andfunction. Annu.Rev. Immunol. 23, 549-600.
10. Bettelli,E.,Carrier,Y.,Gao,W.,Korn,T., Strom,T.B.,Oukka,M.,Weiner,H. L., andKuchroo,V.K. (2006).Recip-rocaldevelopmentalpathwaysfor the generationofpathogeniceffector TH17 andregulatoryTcells. Nature 441, 235-238.
11. Boehme, S.A.,andLenardo,M.J. (1993). Propriocidalapoptosisof matureTlymphocytesoccursatS phase ofthecellcycle. Eur.J. Immunol. 23, 1552-1560.
12. Boise, L.H.,Minn,A.J.,Noel,P. J.,June,C.H.,Accavitti,M.A., Lindsten,T.,andThompson,C.B. (1995). CD28costimulationcanpro-moteTcellsurvivalbyenhancing the expressionofBcl-XL. Immunity 3, 87-98.
13. Cartwright,N.G.,Kashyap,A.K., and Schaefer,B.C. (2011).An activekinasedomainisrequiredfor retentionofPKCthetaattheTcell immunologicalsynapse. Mol.Biol. Cell 22, 3491-3497.
14. Chang, J. D., Xu, Y., Raychowdhury, M. K., and Ware, J. A. (1993). Molecularcloningandexpressionof acDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells,and platelets. J. Biol. Chem. 268, 14208-14214.
15. Chang, J. T., Palanivel, V. R., Kinjyo, I., Schambach, F., Intlekofer, A. M., Banerjee, A., Longworth, S. A., Vinup, K. E., Mrass, P., Oliaro, J., Killeen, N., Orange, J. S., Russell, S. M., Weninger, W., and Reiner, S. L. (2007). Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 315, 1687-1691.
16. Chuang, H. C., Lan, J. L., Chen, D. Y., Yang, C. Y., Chen, Y. M., Li, J. P., Huang, C. Y., Liu, P. E., Wang, X., and Tan, T. H. (2011). The kinase GLKcontrolsautoimmunityandNFkappaB signaling by activating the kinase PKC-theta in T cells. Nat. Immunol. 12, 1113-1118.
17. Clements, J. L. (2003). Known and potential functions for the SLP76 adapter protein in regulating T-cell activation and development. Immunol. Rev. 191, 211-219.
18. Cohen, S., Braiman, A., Shubinsky, G., and Isakov, N. (2011). Protein kinase C-theta in platelet activation. FEBS Lett. 585, 3208-3215.
19. Curotto de Lafaille, M. A., and Lafaille, J. J. (2009). Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30,626-635.
20. Cywin, C. L., Dahmann, G., Prokopowicz, A. S. III, Young, E. R., Magolda, R. L., Cardozo, M. G., Cogan, D. A., Disalvo, D., Ginn, J. D., Kashem, M. A., Wolak, J. P., Homon, C. A., Farrell, T. M., Grbic, H., Hu, H., Kaplita, P. V., Liu, L. H., Spero, D. M., Jeanfavre, D. D., OShea, K. M., White, D. M., Woska, J. R. Jr., and Brown, M. L. (2007). Discovery of potent and selective PKC-theta inhibitors. Bioorg. Med. Chem. Lett. 17, 225-230.
21. Dong, C. (2010). Helper T-cell heterogeneity:acomplexdevelopmental issue in the immune system. Cell. Mol. Immunol. 7, 163.
22. Dustin, M. L. (2009). Modular design of immunological synapses and kinapses. Cold Spring Harb. Perspect. Biol. 1, a002873.
23. Fang, X., Wang, R., Ma, J., Ding, Y., Shang, W., and Sun, Z. (2012). Ameliorated ConA-induced hepatitis in the absence of PKC-theta. PLoS ONE 7,e31174. doi:10.1371/journal. pone.0031174
24. Freiberg,B.A.,Kupfer,H.,Maslanik,W., Delli,J.,Kappler,J.,Zaller,D. M.,and Kupfer, A. (2002). Staging and resetting T cell activation in SMACs. Nat. Immunol. 3,911-917.
25. Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., and Dustin, M. L. (1999). The immunological synapse: a molecular machinecontrollingTcellactivation. Science 285,221-227.
26. Harper, M. T., and Poole, A. W. (2010). Protein kinase Ctheta negativ2e+ly regulates store-independent Ca entry and phosphatidylserine exposure downstream of glycoproteinVIinplatelets. J.Biol. Chem. 285, 19865-19873.
27. Healy, A. M., Izmailova, E., Fitzgerald, M., Walker, R., Hattersley, M., Silva, M., Siebert, E., Terkelsen, J., Picarella, D., Pickard, M. D., LeClair, B., Chandra, S., and Jaffee, B. (2006). PKC-theta-deficient mice are protected from Th1-dependent antigeninduced arthritis. J. Immunol. 177, 1886-1893.
28. Huang, Z., Xie, H., Wang, R., and Sun, Z. (2007). Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunity. Expert. Opin. Ther. Targets 11,737-743.
29. Ishigami, M., Nishimura, H., Naiki, Y., Yoshioka, K., Kawano, T., Tanaka, Y., Taniguchi, M., Kakumu, S., and Yoshikai, Y. (1999). The roles of intrahepatic Valpha14(+) NK1.1(+) T cells for liver injury induced by Salmonella infection in mice. Hepatology 29, 1799-1808.
30. Kaneko, Y., Harada, M., Kawano, T., Yamashita, M., Shibata, Y., Gejyo, F., Nakayama, T., and Taniguchi, M. (2000). Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191,105-114.
31. Kato, A., Yoshidome, H., Edwards, M. J., and Lentsch, A. B. (2000). Regulation of liver inflammatory injury by signal transducer and activator of transcription-6. Am. J. Pathol. 157, 297-302.
32. Kawano, T., Nakayama, T., Kamada, N., Kaneko, Y., Harada, M., Ogura, N., Akutsu, Y., Motohashi, S., Iizasa, T., Endo, H., Fujisawa, T., Shinkai, H., and Taniguchi, M. (1999). Antitumor cytotoxicity mediated by ligandactivated human V alpha24 NKT cells. Cancer Res. 59, 5102-5105.
33. Kempuraj, D., Madhappan, B., Christodoulou, S., Boucher, W., Cao, J., Papadopoulou,N.,Cetrulo,C.L.,and Theoharides, T. C. (2005). Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br. J. Pharmacol. 145,934-944.
34. Kim, C. H., Butcher, E. C., and Johnston, B. (2002). Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol. 23,516-519.
35. Kim, J. K., Fillmore, J. J., Sunshine, M. J.,Albrecht, B., Higashimori, T., Kim, D. W., Liu, Z. X., Soos, T. J., Cline, G. W., OBrien, W. R., Littman, D. R., and Shulman, G. I. (2004). PKCtheta knockout mice are protected fromfat-inducedinsulinresistance.J. Clin. Invest. 114,823-827.
36. Kong, K. F., Yokosuka, T., Canonigo Balancio, A. J., Isakov, N., Saito, T., and Altman, A. (2011). A motif in the V3 domain of the kinase PKC-theta determines its localization in the immunological synapse and functions in T cells via association with CD28. Nat. Immunol. 12, 1105-1112.
37. Kwon, M. J., Ma, J., Ding, Y., Wang, R., and Sun,Z. (2012). Protein kinase Ctheta promotes Th17 differentiation viaupregulationof Stat3.J.Immunol. 188,5887-5897.
38. Kwon, M. J., Wang, R., Ma, J., and Sun, Z. (2010). PKC-theta is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection. Endocr. Metab. Immune Disord. Drug Targets 10, 367-372.
39. Lee, K. H., Holdorf, A. D., Dustin, M. L., Chan, A. C., Allen, P. M., and Shaw, A. S. (2002). T cell receptor signaling precedes immunological synapse formation. Science 295, 1539-1542.
40. Lee, K. Y., DAcquisto, F., Hayden, M. S., Shim, J. H., and Ghosh, S. (2005). PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science 308,114-118.
41. Li, X. C., Strom, T. B., Turka, L. A., and Wells, A. D. (2001). T cell death and transplantation tolerance. Immunity 14,407-416.
42. Li, Y., Hu, J., Vita, R., Sun, B., Tabata, H., and Altman, A. (2004). SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-induced AP-1activationpathway.EMBOJ.23, 1112-1122.
43. Li,Y.,Li,X.C.,Zheng,X.X.,Wells,A.D., Turka, L. A., and Strom, T. B. (1999). Blockingbothsignal1andsignal2of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheralallografttolerance. Nat. Med. 5,1298-1302.
44. Lin, X., and Wang, D. (2004). The rolesofCARMA1,Bcl10,andMALT1 in antigen receptor signaling. Semin. Immunol. 16, 429-435.
45. Lindquist, R. L., Shakhar, G., Dudziak, D., Wardemann, H., Eisenreich, T., Dustin, M. L., and Nussenzweig, M. C. (2004). Visualizing dendritic cell networks in vivo. Nat. Immunol. 5, 1243-1250.
46. Liu, K. Q., Bunnell, S. C., Gurniak, C. B., and Berg, L. J. (1998). T cell receptorinitiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J. Exp. Med. 187,1721-1727.
47. Liu, Y., Graham, C., Li, A., Fisher, R. J., andShaw,S. (2002).Phosphorylation of the protein kinase C-theta activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factorkappaB induction. Biochem. J. 361, 255-265.
48. Ma, J., Ding, Y., Fang, X., Wang, R., and Sun, Z. (2012). Protein kinase C-theta inhibitsinducibleregulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway. J. Immunol. 188,5337-5347.
49. Macian, F., Garcia-Cozar, F., Im, S. H., Horton, H. F., Byrne, M. C., and Rao, A. (2002). Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109,719-731.
50. Manicassamy, S., Gupta, S., Huang, Z., and Sun, Z. (2006a). Protein kinase C-{theta}-mediated signals Eehance CD4+ T Cell survival by up-regulating Bcl-xL. J. Immunol. 176,6709-6716.
51. Manicassamy, S., Gupta, S., and Sun, Z. (2006b). Selective function of PKCtheta in T cells. Cell. Mol. Immunol. 3,263-270.
52. Manicassamy, S., Yin, D., Zhang, Z., Molinero, L. L., Alegre, M. L., and Sun,Z. (2008).Acriticalroleforprotein kinase C-theta-mediated T cell survival in cardiac allograft rejection. J. Immunol. 181,513-520.
53. Marsland, B. J., and Kopf, M. (2008). T-cell fate and function: PKC-theta and beyond. Trends Immunol. 29, 179-185.
54. Marsland, B. J., Nembrini, C., Schmitz, N., Abel, B., Krautwald, S., Bachmann, M. F., and Kopf, M. (2005). Innate signals compensate for the absence of PKC-{theta} during in vivo CD8(+) T cell effector and memory responses. Proc. Natl. Acad. Sci. U.S.A. 102, 14374-14379.
55. Marsland, B. J., Soos, T. J., Spath, G., Littman, D. R., and Kopf, M. (2004). Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J. Exp. Med. 200,181-189.
56. McFarlane, I. G. (1999). Pathogenesis of autoimmune hepatitis. Biomed. Pharmacother. 53,255-263.
57. Miyara, M., and Sakaguchi, S. (2007). Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med.13,108-116.
58. Monks, C. R., Freiberg, B. A., Kupfer, H., Sciaky, N., and Kupfer, A. (1998). Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395,82-86.
59. Monks, C. R., Kupfer, H., Tamir, I., Barlow, A., and Kupfer, A. (1997). Selective modulation of protein kinase C-theta during T-cell activation. Nature 385, 83-86.
60. Moran, M., and Miceli, M. C. (1998). Engagement of GPI-linked CD48contributestoTCRsignalsand cytoskeletal reorganization: a role for lipid rafts in T cell activation. Immunity 9,787-796.
61. Morgan, M. M., Labno, C. M.,Van Seventer, G. A., Denny, M. F., Straus, D. B., and Burkhardt, J. K. (2001). Superantigen-induced T cell:B cell conjugation is mediated by LFA-1 and requires signaling through Lck, but not ZAP-70. J. Immunol. 167, 5708-5718.
62. Mosyak, L., Xu, Z., Joseph-McCarthy, D., Brooijmans, N., Somers, W., and Chaudhary, D. (2007). Structurebased optimization of PKCtheta inhibitors. Biochem. Soc. Trans. 35, 1027-1031.
63. Murphy,K. M.,and Reiner,S. L. (2002). The lineage decisions of helper T cells. Nat. Rev. Immunol. 2, 933-944.
64. Nagy, B. Jr., Bhavaraju, K., Getz, T., Bynagari, Y. S., Kim, S., and Kunapuli,S.P. (2009). Impaired activation of platelets lacking protein kinase Ctheta isoform. Blood 113,2557-2567.
65. Newton, A. C. (1997). Regulation of protein kinase C. Curr. Opin. Cell Biol. 9, 161-167.
66. Noel,P.J.,Boise,L.H.,Green,J.M.,and Thompson, C. B. (1996). CD28 costimulation prevents cell death during primaryTcellactivation. J.Immunol. 157,636-642.
67. Osada, S., Mizuno, K., Saido, T. C., Suzuki, K., Kuroki, T., and Ohno, S. (1992).Anewmemberof theprotein kinaseCfamily,nPKCtheta,predominantly expressed in skeletal muscle. Mol. Cell. Biol. 12,3930-3938.
68. Paoletti, R., Maffei, A., Madaro, L., Notte, A., Stanganello, E., Cifelli, G., Carullo, P., Molinaro, M., Lembo, G., and Bouche, M. (2010). Protein kinase Ctheta is required for cardiomyocyte survival and cardiac remodeling. Cell Death Dis. 1,e45.
69. Pfeifhofer, C., Kofler, K., Gruber, T., Tabrizi,N.G.,Lutz,C.,Maly,K.,Leitges, M., and Baier, G. (2003). Protein kinase C theta affects Ca mobilization and NFAT cell activation in primary mouse T cells. J. Exp. Med. 197,1525-1535.
70. Radvanyi, L. G., Shi, Y., Vaziri, H., Sharma, A., Dhala, R., Mills, G. B., and Miller, R. G. (1996). CD28 costimulation inhibits TCRinduced apoptosis during a primary T cell response. J. Immunol. 156, 1788-1798.
71. Reddy, P., Maeda, Y., Liu, C., Krijanovski, O. I., Korngold, R., and Ferrara. J. L. (2005). A crucial role for antigen-presenting cells and alloantigen expression in graftversus-leukemiaresponses.Nat.Med. 11,1244-1249.
72. Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., and Nomura, T. (2006). Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8-27.
73. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
74. Sakaguchi, S., Yamaguchi, T., Nomura, T., and Ono, M. (2008). Regulatory T cells and immune tolerance. Cell 133,775-787.
75. Salek-Ardakani, S., So, T., Halteman, B. S., Altman, A., and Croft, M. (2005). Protein kinase Ctheta controls Th1 cells in experimental autoimmune encephalomyelitis. J. Immunol. 175, 7635-7641.
76. Salek-Ardakani, S., So, T., Halteman, B. S., Altman, A., and Croft, M. (2004). Differential regulation of Th2 and Th1 lung inflammatory responses by protein kinase C theta. J. Immunol. 173,6440-6447.
77. Shaulian, E., and Karin, M. (2002). AP1 as a regulator of cell life and death. Nat. Cell Biol. 4,E131-E136.
78. Shevach, E. M. (2006). From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25, 195-201.
79. Shevach, E. M., DiPaolo, R. A., Andersson, J., Zhao, D. M., Stephens, G. L., and Thornton, A. M. (2006). The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol. Rev. 212, 60-73.
80. Shlomchik, W. D. (2007). Graft-versushost disease. Nat. Rev. Immunol. 7, 340-352.
81. Sims, T. N., Soos, T. J., Xenias, H. S., Dubin-Thaler, B., Hofman, J. M., Waite, J. C., Cameron, T. O., Thomas, V. K., Varma, R., Wiggins, C. H., Sheetz, M. P., Littman, D. R., and Dustin, M. L. (2007). Opposing effects of PKCtheta andWASp on symmetry breaking and relocation of the immunological synapse. Cell 129, 773-785.
82. Singh, B., Read, S.,Asseman, C., Malmstrom, V., Mottet, C., Stephens, L. A., Stepankova, R., Tlaskalova, H., and Powrie, F. (2001). Control of intestinalinflammationbyregulatory T cells. Immunol. Rev. 182,190-200.
83. Skvara, H., Dawid, M., Kleyn, E., Wolff, B., Meingassner, J. G., Knight, H., Dumortier, T., Kopp, T., Fallahi, N., Stary, G., Burkhart, C., Grenet, O., Wagner, J., Hijazi, Y., Morris, R. E., McGeown, C., Rordorf, C., Griffiths, C. E., Stingl, G., and Jung, T. (2008). The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J. Clin. Invest. 118,3151-3159.
84. Somersalo,K.,Anikeeva,N.,Sims,T.N., Thomas,V.K.,Strong,R.K.,Spies,T., Lebedeva, T., Sykulev,Y., and Dustin, M. L. (2004). Cytotoxic T lymphocytes form an antigen-independent ring junction. J. Clin. Invest. 113, 49-57.
85. Suchin, E. J., Langmuir, P. B., Palmer, E., Sayegh, M. H., Wells, A. D., and Turka, L. A. (2001). Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166,973-981.
86. Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., and Littman, D. R. (2000). PKCtheta is required for TCR-induced NF-kappaB activation in mature but notimmatureTlymphocytes.Nature 404,402-407.
87. Tan, S. L., Zhao, J., Bi, C., Chen, X. C., Hepburn, D. L., Wang, J., Sedgwick, J. D., Chintalacharuvu, S. R., and Na, S. (2006). Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice. J. Immunol. 176,2872-2879.
88. Tomlinson, M. G., Kane, L. P., Su, J., Kadlecek, T. A., Mollenauer, M. N., and Weiss, A. (2004). Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec. Mol. Cell. Biol. 24,2455-2466.
89. Valenzuela, J. O., Iclozan, C., Hossain, M. S., Prlic, M., Hopewell, E., Bronk, C. C., Wang, J., Celis, E., Engelman, R. W., Blazar, B. R., Bevan, M. J., Waller, E. K., Yu, X. Z., and Beg, A. A. (2009). PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. J. Clin. Invest. 119,3774-3786.
90. Van Parijs, L., Ibraghimov, A., and Abbas,A. K. (1996). The roles of costimulationandFasinTcellapoptosis and peripheral tolerance. Immunity 4,321-328.
91. Varma, R., Campi, G., Yokosuka, T., Saito, T., and Dustin, M. L. (2006). T cell receptorproximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 25, 117-127.
92. Villalba, M., Bushway, P., and Altman, A. (2001). Protein kinase Ctheta mediates a selective T cell survival signal via phosphorylation of BAD. J. Immunol. 166, 59555963.
93. Wan,Y.Y.,andDeGregori,J., (2003).The survival of antigen-stimulated T cells requires NFkappaB-mediated inhibition of p73 expression. Immunity 18, 331-342.
94. Wang, L., Xiang, Z., Ma, L. L., Chen, Z., Gao, X., Sun, Z., Williams, P., Chari R.S.,andYin,D.P., (2009).Deficiency of protein kinase C-theta facilitates tolerance induction. Transplantation 87, 507-516.
95. Weil, R., and Israel, A. (2004). Tcell-receptorand B-cell-receptormediatedactivation of NF-kappaBin lymphocytes. Curr. Opin. Immunol. 16, 374-381.
96. Weil, R., Schwamborn, K., Alcover, A., Bessia, C., Di Bartolo, V., and Israel, A. (2003). Induction of the NF-kappaB cascade by recruitment of the scaffold molecule NEMO to the T cell receptor. Immunity 18, 13-26.
97. Weiss, A., and Littman, D. R. (1994). Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
98. Wells, A. D., Li, X. C., Li, Y., Walsh, M. C., Zheng, X. X., Wu, Z., Nunez, G., Tang, A., Sayegh, M., Hancock, W. W., Strom, T. B., and Turka, L. A. (1999). Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat. Med. 5,1303-1307.
99. Zanin-Zhorov, A., Ding, Y., Kumari, S., Attur, M., Hippen, K. L., Brown, M., Blazar, B. R., Abramson, S. B., Lafaille, J. J., and Dustin, M. L. (2010). Protein kinase Ctheta mediates negative feedback on regulatory T cell function. Science 328, 372-376.
100. Zhou, L., Lopes, J. E., Chong, M. M., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y., Du, J., Rubtsov, Y. P., Rudensky, A. Y., Ziegler, S. F., and Littman, D. R. (2008). TGFbeta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammatfunction. Nature 453, 236-240.